SME Times is powered by   
Search News
Just in:   • India’s pharmaceutical exports exceed $28 billion up to February  • Bangladesh faces economic strain as Iran war pushes up fuel and food costs  • India’s major ports handled record 915.17 million tonnes of cargo in FY26  • Over 51 lakh LPG cylinders delivered in a day, no dry-out at gas agencies: Centre  • Govt launches programme to train scientists in Governance under Mission Karmayogi 
Last updated: 01 Feb, 2017  

cadila.thumb.jpg Cadila Healthcare net profit declines 34.6 pc in Q3

cadila.jpg
   Top Stories
» Govt launches programme to train scientists in Governance under Mission Karmayogi
» India's fisheries sector draws Rs 39,272 crore investment since 2015, seafood exports double
» India’s exports to Australia more than double after bilateral trade pact
» India IPO market hits highest Q1 since 2018, raises $2.5 billion
» India’s defence exports surge 62.6 pc to Rs 38,424 crore in FY26, reach over 80 countries
SME Times News Bureau | 01 Feb, 2017
Global pharmaceutical company Cadila Healthcare on Tuesday posted a 34.6 percent decline in its consolidated net profit to Rs 281.6 crore for the quarter ended December 31, 2016 as compared with Rs 430.5 crore in the year-ago period.

The company's consolidated total income from operations also dipped to Rs 2,363.8 crore during the quarter under review as compared with Rs 2,408.9 crore in a year-ago period.

On BSE, the stock settled at Rs 349.25, down 7.02 percent from the previous close.
 
Print the Page Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
₹94.25
₹92.55
UK Pound
₹125.95
₹121.95
Euro
₹108.95
₹105.3
Japanese Yen ₹59.4 ₹57.6
As on 02 Apr, 2026
  Daily Poll
What is the biggest war impact on MSMEs?
 Export Disruption
 Raw Material Spike
 Freight Cost Surge
 Payment Delays
 Currency Volatility
 All
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter